Indication
Treatment of breast cancer, special forms of lung cancer (non-small-cell lung cancer), prostate cancer, gastric cancer, or head and neck cancer.
Loading your page…
Loading your page…
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Breast Neoplasms
Marketing Authorisation Holder: Mylan S.A.S.
EMA Authorisation: 31/01/2012
INN: docetaxel
AI Drug & Interaction Analysis
Free account required
Ask Osler about Docetaxel Mylan: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.